{"ORPHApacket":[{"ORPHApacketID":"31154","date":"2019-07-19 09:23:18","version":"1.2.11 \/ 4.1.6 [2018-04-12] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"31154","Name":[{"lang":"en","label":"Hypobetalipoproteinemia"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_31154","DisorderType":[{"Name":[{"lang":"en","label":"Group of phenomes"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377794"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Rare hypolipidemia"}],"ORPHA":"181431","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_181431"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Disease definition"}],"Contents":"Hypobetalipoproteinemia (HBL) constitutes a group of lipoprotein metabolism disorders that are characterized by permanently low levels (below the 5th percentile) of apolipoprotein B and LDL cholesterol."}]}]}